World's First Cardiac Adult Stem Cell Patient Receives Infusion

Trial taking place in Louisville, KY LOUISVILLE, Ky., July 24 /PRNewswire-USNewswire/ -- Michael (Mike) Jones has become the world's first recipient of adult cardiac stem cells to treat congestive heart failure. Jones' infusion on July 17 marks the world's first phase-one...

Leading Experts Endorse Bioheart's Muscle Stem Cell MyoCell Therapy

SUNRISE, Fla., July 7 /PRNewswire-FirstCall/ -- Bioheart, Inc., (OTC Bulletin Board: BHRT) announced today that the panel discussion on myoblast (muscle stem cell) therapy between distinguished physicians and scientists is available for playback at the following site: http://www.bioheartin...

UPCI Joins ExCell Research Study Using Stem Cells for Leukemia and Lymphoma Patients

PITTSBURGH, Pennsylvania, and JERUSALEM, Israel, June 15 /PRNewswire/ -- The University of Pittsburgh Cancer Institute (UPCI) and the Gamida Cell - Teva Joint Venture announced today that the Institute has joined an elite group of cancer centers in Europe, the United States and Israel that a...

Three Surgeons in East Texas Are Successfully Integrating a Novel Stem Cell Procedure for Spine Surgeries

Stem Cell Technologies for Surgery TEXARKANA, Texas, June 5 /PRNewswire/ -- A new breakthrough in adult stem cell technology has three Texarkana neurosurgeons leading their industry by utilizing concentrated stem cells for spine surgery. The innovative technique is improving the desired resul...

Cardiogenesis Announces Presentation of its PHOENIX(R) Combination TMR Plus Stem Cell Delivery System at the International Society of Minimally Invasive Cardiothoracic Surgeons (ISMICS) Annual Meeting

IRVINE, Calif., June 4 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (Pink Sheets: CGCP) the market leader in laser transmyocardial revascularization (TMR) for the treatment of chronic cardiac ischemia, announces that Dr. Naresh Trehan of New Delhi will be presenting his clinical results of ...

Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support

Small Molecule Stem Cell Modulator Administered in Dual Cord Blood Transplant for Hematologic Malignancy LA JOLLA, Calif., May 27 /PRNewswire/ -- Fate Therapeutics, Inc. announced today that the first patient has been treated in a Phase 1b clinical trial of FT1050, a small molecule Stem C...

New Federal Stem Cell Rules Would Hinder Existing Research, Consumer Group Warns

NIH Should Fix Standards to Allow Use of Current Stem Cell Lines SANTA MONICA, Calif., May 20 /PRNewswire-USNewswire/ -- -- Regulations governing stem cell research proposed by the Obama Administration -- unless modified before final implementation on July 1 -- prohibit federal fund...

BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available

ARLINGTON, Va., May 5 /PRNewswire/ -- BioInformatics, LLC announces the release of its newest report, Capitalizing on New Opportunities for Stem Cell Products. Despite a sluggish economy and cuts being made to laboratory budgets, the market for stem cell research products is expected to increa...

Discovery of Marker for Colon Stem Cells Could Shed Light on What Drives Tumor Growth

WILMINGTON, Del., April 7 /PRNewswire/ -- Cancer researchers led by Bruce Boman, M.D., Ph.D. director of Cancer Genetics and Stem Cell Biology at the Helen F. Graham Cancer Center of the Christiana Care Health System, and a faculty member at the University of Delaware , have discovered an enzyme ...

Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack

SAN DIEGO, March 27 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM ) today reported on an NIH-funded, pre-clinical study conducted by independent researchers at the University of Cincinnati entitled IGF-1--Overexpressing Mesenchymal Stem Cells Accelerate Bone Marrow Stem Cell ...

MultiCell Technologies Signs Liver Stem Cell R&D Agreement To Develop Products for the Study of Liver Cancer

WOONSOCKET, R.I., March 19 /PRNewswire-FirstCall/ --MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) announced today that it has entered into a cooperative research and development agreement with Maxim Biotech, Inc. to develop products for the study of liver stem cells and liver cancer. ...

Roundtable Calls President's Embryonic Stem Cell Decision: Bankrupt

CLEVELAND, March 9 /PRNewswire-USNewswire/ -- In response to the President's actions today changing federal policy on embryonic stem cell research, David Zanotti, CEO of the American Policy Roundtable and Dr. Charles McGowen, M.D., Chief Medical Advisor for the Roundtable, issued the following sta...

Neuralstem's Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS

Make Synaptic Contact with Host Motor Neurons ROCKVILLE, Md., March 9 /PRNewswire-FirstCall/ -- Transplanted human neural stem cells (hNSCs) developed by Neuralstem, Inc. (NYSE Alternext US: CUR) made synaptic contacts with the motor neurons of rats with ALS-like symptoms, a paper published i...

New Study Using Combination of Bioengineered Skin and Stem Cells Shows Promise in Treatment of Non-Healing Wounds

SAN FRANCISCO, March 5 /PRNewswire-USNewswire/ -- Scleroderma is an autoimmune disease that leads to thickening and severe scarring of skin as well as thickening and failure of internal organs, including the lungs, heart, kidneys and intestines. The disease -- which the Scleroderma Foundation esti...

Michigan Catholic Conference Welcomes Announcement of Non-Embryo Destructive Stem Cell Research Advancement

LANSING, Mich., March 2 /PRNewswire-USNewswire/ -- Michigan Catholic Conference Vice President for Public Policy Paul Long made the following statement today regarding a study in the online journal Nature, and reported in today's Washington Post, that stem cell researchers have discovered an addit...

Wayne County Partners With TechTown to Launch Global Stem Cell 'Innovation and Commercialization Lab'

2,500-square-foot 'open lab' will serve as international hub for collaborative research, biotech start-ups DETROIT, Feb. 16 /PRNewswire-USNewswire/ -- TechTown, the Wayne State University research and technology park, will soon be home to the first stem cell commercialization lab in Michiga...

Groundbreaking Paper Publishes Long Term Results of a Successful Phase I Clinical Trial Using Autologous Neural Stem Cells to Treat Parkinson's Disease

LOS ANGELES, Feb. 16 /PRNewswire/ -- Scientists announced today the publication of a landmark peer-reviewed paper in the February issue of the Bentham Open Stem Cell Journal which outlines the long term results of the world's first clinical trial using autologous neural stem cells for the trea...

FDA Stem Cell Approval Breakthrough Laudable

SAN CLEMENTE, Calif., Jan. 23 /PRNewswire/ -- Today the FDA announced approval for the first clinical trials on humans using Embryonic Stem Cells but Adult Stem Cell scientist Christian Drapeau says the experts may not be telling the whole story; Adult Stem Cells have greater potential with le...

UK Must Maintain its Momentum in Stem Cell Expertise

LONDON, January 19 /PRNewswire/ -- Excalibur, the international investment house specialising in medical sciences, said today the UK must 'maintain its momentum' to deliver pioneering stem cell treatments if it is to remain at the forefront of medical technology. Professor Sir Christoph...

Gene Marker May Improve Odds of Stem Cell Therapies for Disease

PHILADELPHIA, Jan. 9 /PRNewswire-USNewswire/ -- A single tumor-suppressor gene may provide a unique marker for senescence in Mesenchymal stem cells (MSCs) in vitro, while also playing a role in moving MSCs into senescence, researchers at the Human Health Foundation and the Sbarro Institute for Can...

Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source

St. Jude scientists show for the first time that normal stem cells can act as the source of tumors in mature solid tissues MEMPHIS, Tenn., Dec. 17 /PRNewswire-USNewswire/ -- Scientists at St. Jude Children's Research Hospital have answered a central question in cancer biology: whether n...

Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes

SAN FRANCISCO, Dec. 7 /PRNewswire-USNewswire/ -- Two studies examining the effects of stem cell source and patient age on stem cell transplantation outcomes will be explored at a press conference taking place on Sunday, December 7, at 8:00 a.m., during the 50th Annual Meeting of the American Socie...

Open Letter to President-Elect Barack Obama From Don Margolis, Chairman and Founder of The Repair Stem Cell Institute

WASHINGTON, Nov. 24 /PRNewswire-USNewswire/ -- Dear President-Elect Obama: Your first four year Presidential term will start with billions of dollars earmarked for stem cell research. As spokesman for the Repair Stem Cell Institute (RSCI), which is the voice of the Repair Stem C...

Technique for Rapidly Reprogramming Adult Cells Into Stem Cells Published in PLoS Biology

- Technology In-Licensed by Stem Cell Sciences From University of Cambridge - ("Stem Cell Sciences", "SCS", "the Company") CAMBRIDGE, England, Oct. 24 /PRNewswire/ -- Stem Cell Sciences plc (AIM: STEM, ASX: STC), a company focused on the commercialisation of stem cells and stem cell ...

Consumer Group Urges Gov. Schwarzenegger to Sign Stem Cell Bill Into Law

SANTA MONICA, Calif., Sept. 15 /PRNewswire-USNewswire/ -- Gov. Arnold Schwarzenegger should sign a stem cell public accountability bill, SB1565, into law, Consumer Watchdog said today. The bill, sponsored by Sen. Sheila Kuehl and Sen. George Runner, was passed with overwhelming bipartisan supp...

Stem Cell Sciences Announces the Creation of the World's First Authentic Rat Embryonic Stem Cells from its Exclusively Licensed Technology

CAMBRIDGE, England, September 2 /PRNewswire-FirstCall/ -- - ("Stem Cell Sciences", "SCS", "the Company") Stem Cell Sciences plc (AIM:STEM, ASX:STC), a company focused on the commercialisation of stem cells and stem cell technologies, is pleased to announce that two independent laboratories...

DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties

Spraying Set for Tonight in Parts of Bucks, Delaware, Montgomery, Philadelphia Counties NORRISTOWN, Pa., Aug. 27 /PRNewswire-USNewswire/ -- After encouraging results following the first night of aerial treatments, the Department of Environmental Protection will continue its efforts this eveni...

CMV Disease in Stem Cell Transplantation: Prevention and Drug Resistance

A Complimentary Continuing Education Activity VOORHEES, N.J., Aug. 14 /PRNewswire/ -- Cytomegalovirus (CMV) is a significant cause of morbidity and mortality in recipients of hematopoietic stem cell transplantation. The clinical manifestations of CMV disease are serious and range ...

Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells

ASPS Study Finds Some Areas of the Body Have Greater Concentrations of Stem Cells ARLINGTON HEIGHTS, Ill., July 23 /PRNewswire-USNewswire/ -- Fat removed from the lower abdomen and inner thigh through liposuction was found to be an excellent source of stem cells, with higher stem cell concen...

Cardiogenesis Announces Preliminary Clinical Results With the PHOENIX System Combining TMR + Stem Cells

IRVINE, Calif., June 12 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (Pink Sheets: CGCP), a leading developer of surgical products for cardiac revascularization, today announced a scientific presentation that describes the use of the PHOENIX delivery system combining transmyocardial rev...

Brain Stem Cells Can Be Awakened, Say Schepens Scientists

Study Findings Promise to help in treatment of brain diseases BOSTON, June 6 /PRNewswire/ -- Scientists at Schepens Eye Research Institute have identified specific molecules in the brain that are responsible for awakening and putting to sleep brain stem cells, which, when activated, can t...

ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients

- Phase 3 Study in 681 Stem Cell Transplant Patients Represents First Pivotal Study on a New Antiviral CMV Therapy in Stem Cell Transplant in Over a Decade - - Company Also Provides Timing of Phase 3 Data Disclosure and Regulatory Submi...

California Stem Cell Agency Exaggerated Its Role in Funding Key Research

Agency Claimed State Funding Led to Important Clinical Trials SANTA MONICA, Calif., April 16 /PRNewswire-USNewswire/ -- California's stem cell agency overstated and hyped the importance of its funding in enabling clinical trials for a drug to treat a severe blood disorder, Consumer Watchdo...

Texas Heart(R) Institute at St. Luke's Episcopal Hospital Initiates First Clinical Trial in the World to Treat a Heart Attack Patient with a Special Stem Cell Type

HOUSTON, April 14 /PRNewswire-USNewswire/ -- Physician scientists at the Texas Heart Institute (THI) at St. Luke's Episcopal Hospital announced they have begun the world's first clinical trial to treat heart attack patients with a special type of stem cell to promote better healing and to prev...

Family of Three Americans Become Pain Free and Improve Their Quality of Life With Stem Cell Treatment in Mexico

MONTERREY, Mexico, March 20 /PRNewswire/ -- Optimum Health Regeneration Center announced the successful treatment of an American family treated for pain management and impaired mobility. This New Mexico family, ranging in age from 52 to 78, all recorded significant improvements in reduced pain...

NeoStem Reports Positive Stem Cell Industry Research Trends From The Journal of the American Medical Association and Third Annual Stem Cell Summit

Multiple Clinical Applications for Blood-Derived Stem Cells and Strong Industry Outlook Support NeoStem's Business Model NEW YORK, Feb. 28 /PRNewswire-FirstCall/ -- NeoStem, Inc. (Amex: NBS ), which is pioneering the pre-disease collection, processing and long-term storage of adult...

SpineSmith Partners to Present at 3rd Annual Stem Cell Summit

AUSTIN, Texas, Feb. 25 /PRNewswire/ -- SpineSmith Partners, LP, a biotech medical device company that focuses on new treatments for spinal disorders, announced today that Dr. Robert G. Johnson, MD, and Dr. Stuart Williams, PhD, are scheduled to present at the 3rd Annual Stem Cell Summit in New...

A Functional Immune System Can Be Derived From Embryonic Stem Cells, Preliminary Study Finds

WASHINGTON, Feb. 12 /PRNewswire-USNewswire/ -- A new study demonstrates for the first time that embryonic stem cells can be used to create functional immune system blood cells, a finding which is an important step in the utilization of embryonic stem cells as an alternative source of cells for...

Derma Sciences to Enter Phase II Development of Wound Healing Product That May Use Body's Own Naturally Occurring Stem Cells

Appoints U.S. Biotest to Oversee Trials PRINCETON, N.J., Jan. 24 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced today that it has signed a clinical services agreement with San Luis Obispo-based, p...

New Conflict of Interest Violations Revealed at California Stem Cell Institute

Tainted Research Grant Applications Must Be Rejected, Consumer Advocates Say SANTA MONICA, Calif., Dec. 7 /PRNewswire-USNewswire/ -- More apparent conflict of interest violations in applications for research grants in California's $6 billion stem cell program were revealed today and the Fo...